GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Carmike Cinemas, Inc. (CKEC) [hlAlert]

Rating:
Above Average
CKEC
down 45.25 %

Carmike Cinemas, Inc. (CKEC) upgraded to Above Average by Caris & Company

Posted on: Monday,  Oct 22, 2012  8:25 AM ET by Caris & Company

Caris & Company rated Above Average Carmike Cinemas, Inc. (NASDAQ: CKEC) on 10/22/2012. Previously Caris & Company rated Below Average Carmike Cinemas, Inc. (NASDAQ:
CKEC) on 12/08/2011., when the stock price was $7.09. Since then, Carmike Cinemas, Inc. has gained 82.65% as of 10/22/2012's recent price of $12.95.
If you would have followed the previous Caris & Company's recommendation on CKEC, you would have lost 45.25% of your investment in 319 days.

Carmike Cinemas, Inc. is a motion picture exhibitor in the United States. As of December 31, 2008, it owned, operated or had an interest in 250 theatres with 2,287 screens located in 36 states. As of December 31, 2008, the Company had 231 theatres (92% of its theatres) with 2,157 screens (94% of its screens) on a digital-based platform. In addition, it had 193 theatres (77% of its theatres) with 452 screens (20% of its screens) equipped for three-dimensional (3-D). During the year ended December 31, 2008, it operated 22 theatres with 131 screens as discount theatres. The majority of its revenues come from the sale of movie tickets. As of December 31, 2008, of Carmike Cinemas, Inc.?s 250 theatres, 228 showed first-run films, which it licenses from distributors owned by the studios, as well as from independent distributors, nine of which exhibited first-run films at an admission price, and the remaining 22 of its theatres featured films at a discount price.

Caris & Company, an investment bank created by a diverse group of leading Wall Street professionals. We are founded on the basic principle that Wall Street requires a different type of organization: One that offers objective, conflict-free research, acute focus on customer service, broad institutional coverage, and an unwavering commitment to increasing the value of our clients' portfolios. Quite simply, our goal is to generate solid investment ideas for our clients. We offer a unique, differentiated, conflict-free research perspective on large, mid, and small capitalization companies in four growth oriented verticals: Health Care, Technology, Energy, and Consumer.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/22/2012 8:25 AM Buy
None
12.95
as of 12/31/2012
1 Week up  6.15 %
1 Month down  -0.79 %
3 Months up  1.03 %
1 YTD down  -72.39 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/8/2011 9:25 AM Sell
None
7.09 6.00
8/3/2010 9:25 AM Hold
None
6.55 7.00
5/21/2010 9:25 AM Hold
None
11.80 11.00
4/8/2010 9:25 AM Sell
None
15.58 11.00
3/2/2010 9:25 AM Hold
None
10.40 9.00
12/10/2009 9:25 AM Hold
None
7.07
11/20/2009 9:25 AM Buy
None
5.99 7.50
10/14/2009 9:25 AM Hold
None
10.40 11.00
8/18/2009 9:25 AM Buy
None
8.85 11.00
6/10/2009 9:25 AM Hold
None
8.69
10/1/2008 9:25 AM Buy
None
3.68
7/29/2008 8:25 AM Hold
None
6.44 7.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy